Domiodol

Domiodol

SCHEMBL19352

OCC1COC(CI)O1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Domiodol SCHEMBL11633809 1.00
SCHEMBL252279 0.83
SCHEMBL19694 0.83 PRKD3 (0.36)
SCHEMBL9181813 0.77
SCHEMBL12535579 0.77
SCHEMBL11153107 0.77
SCHEMBL9172771 0.77
SCHEMBL4864294 0.77
SCHEMBL4876623 0.74 PRKD3 (0.46)
SCHEMBL10817323 0.74 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2050 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332088-A1 SUSTAINED RELEASE COMPOSITIONS RUBICON RES PRIVATE LIMITED (IN) 2025-10-30 US claimed
US-20250255781-A1 PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-08-14 US claimed
US-12296043-B2 Liquisoft capsules PATHEON SOFTGELS INC. (US) 2025-05-13 US claimed
EP-4510999-A1 PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS Bristol-Myers Squibb Company (US) 2025-02-26 EP claimed
US-20240165020-A1 LIQUISOFT CAPSULES PATHEON SOFTGELS INC (US) 2024-05-23 US claimed
EP-4360653-A2 LIQUISOFT CAPSULES Patheon Softgels Inc. (US) 2024-05-01 EP claimed
US-11872307-B2 Liquisoft capsules PATHEON SOFTGELS INC. (US) 2024-01-16 US claimed
EP-3682872-B1 LIQUISOFT CAPSULES PATHEON SOFTGELS INC (US) 2024-01-03 EP claimed
WO-2023227817-A1 NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) 2023-11-30 WO claimed
WO-2023205619-A1 PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-10-26 WO claimed
WO-2001070242-A2 COMPOSITIONS CONTAINING MOLECULAR IODINE BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2001-09-27 WO claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
WO-2001012584-A2 PHARMACEUTICAL COMPOUNDS NICOX S.A. (FR) 2001-02-22 WO claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
US-6160020-A Alkali metal and alkaline-earth metal salts of acetaminophen MCNEILL-PPC, INC. (US) 2000-12-12 US claimed
WO-2000061549-A2 PHARMACEUTICAL COMPOUNDS NICOX S.A. (FR) 2000-10-19 WO claimed
WO-2000050050-A1 MULTIPARTICULATE FORMULATION ISIS PHARMACEUTICALS, INC. (US) 2000-08-31 WO claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
WO-1999066919-A1 PHARMACEUTICAL COMPOSITION CONTAINING A SALT OF ACETAMINOPHEN AND AT LEAST ONE OTHER ACTIVE INGREDIENT MCNEIL-PPC, INC. (US) 1999-12-29 WO claimed
US-4085223-A Halogenated derivatives of 1,3-dioxolane having mucolytic activity MAGGIONI & C. S.P.A. (IT) 1978-04-18 US claimed